[Basis of immunocorrective therapy among patients with chronic osteomyelitis].
The application of Dimexid and Dekaris is shown to give better results in the treatment of patients with chronic osteomyelitis.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology; D002908:Chronic Disease; D004121:Dimethyl Sulfoxide / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010019:Osteomyelitis / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D007978:Levamisole; D004121:Dimethyl Sulfoxide
Obosnovanie immunokorrigiruiushcheĭ terapii u bol'nykh khronicheskim osteomielitom.